Latest Lead News

SciDev Ltd has announced an immediate CEO transition with CFO Todd Scott stepping up to lead, as outgoing CEO Seán Halpin moves to an advisory role. The company also names John Gardiner as interim CFO while seeking a permanent replacement.

Impact Minerals reports strong assay results from Commonwealth South, confirming polymetallic continuity and setting the stage for a July drilling expansion by JV partner Kuniko.

Fisher & Paykel Healthcare posted a 14% revenue increase to NZ$2.31 billion and a 24% rise in net profit to NZ$468.5 million for FY2026, driven by strong hospital product sales and ongoing innovation.

Pure Foods Tasmania appoints Robert Knight as CEO and Managing Director, aligning leadership with shareholder interests amid ongoing growth and turnaround efforts.

Hydrix Limited has launched the retail phase of its accelerated entitlement offer aiming to raise up to $8.18 million by issuing six new shares per existing share at $0.005 each, plus free options. The institutional component has closed, and retail shareholders have until 5 June to participate.

Anax Metals has closed the second tranche of its placement, raising $4.8 million through a share issue that included $1.1 million from directors and granted options to its lead manager.

Haranga Resources has delivered a maiden JORC Mineral Resource Estimate of 402,000 ounces at 5.1 g/t gold from its Lincoln Gold Project in California, underpinning rapid restart plans backed by $90 million in existing infrastructure.

Anteris Technologies Global Corp. has initiated an at-the-market equity offering to raise up to US$250 million, aiming to accelerate development of its DurAVR transcatheter heart valve and support general corporate needs.

Lincoln Minerals has raised A$3.1 million in a two-tranche placement to fund drilling at its Minbrie Copper Project, with a strategic investor gaining board representation rights.

AdAlta has engaged specialist advisors to streamline US FDA regulatory processes for its CAR-T therapy BZDS1901, which has shown rare complete tumour clearance in advanced mesothelioma patients.

Vectus Biosystems has secured $791,000 through a placement to accelerate its lead fibrosis drug VB0004's Phase IB clinical trial and advance other drug candidates.

Ballymore Resources has pushed the boundaries of its Torpy’s silver-lead-zinc-indium discovery in North Queensland, with initial results from a fresh 3,000m drilling campaign revealing broad zones of massive sulphide mineralisation closer to surface. Assays are due in June, while a government-backed gravity survey aims to unlock further targets across the Ruddygore corridor.